List of Tables
Table 1. Global Dosage Control Syringe Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dosage Control Syringe Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dosage Control Syringe Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dosage Control Syringe Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Dosage Control Syringe Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)
Table 7. Global Dosage Control Syringe Sales by Region (2020-2025) & (M Units)
Table 8. Global Dosage Control Syringe Sales by Region (2026-2031) & (M Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Dosage Control Syringe Sales by Manufacturers (2020-2025) & (M Units)
Table 11. Global Dosage Control Syringe Sales Share by Manufacturers (2020-2025)
Table 12. Global Dosage Control Syringe Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Dosage Control Syringe Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Dosage Control Syringe by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dosage Control Syringe as of 2024)
Table 16. Global Dosage Control Syringe Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Dosage Control Syringe Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Dosage Control Syringe Manufacturing Base and Headquarters
Table 19. Global Dosage Control Syringe Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Dosage Control Syringe Sales by Type (2020-2025) & (M Units)
Table 23. Global Dosage Control Syringe Sales by Type (2026-2031) & (M Units)
Table 24. Global Dosage Control Syringe Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Dosage Control Syringe Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Dosage Control Syringe ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Dosage Control Syringe Sales by Application (2020-2025) & (M Units)
Table 29. Global Dosage Control Syringe Sales by Application (2026-2031) & (M Units)
Table 30. Dosage Control Syringe High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Dosage Control Syringe Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Dosage Control Syringe Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Dosage Control Syringe ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Dosage Control Syringe Growth Accelerators and Market Barriers
Table 37. North America Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Dosage Control Syringe Growth Accelerators and Market Barriers
Table 40. Europe Dosage Control Syringe Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Dosage Control Syringe Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Dosage Control Syringe Growth Accelerators and Market Barriers
Table 45. Southeast Asia Dosage Control Syringe Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Dosage Control Syringe Investment Opportunities and Key Challenges
Table 47. Central and South America Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Dosage Control Syringe Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Dosage Control Syringe Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. B.Braun Corporation Information
Table 51. B.Braun Description and Major Businesses
Table 52. B.Braun Product Models, Descriptions and Specifications
Table 53. B.Braun Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. B.Braun Sales Value Proportion by Product in 2024
Table 55. B.Braun Sales Value Proportion by Application in 2024
Table 56. B.Braun Sales Value Proportion by Geographic Area in 2024
Table 57. B.Braun Dosage Control Syringe SWOT Analysis
Table 58. B.Braun Recent Developments
Table 59. Bayer Corporation Information
Table 60. Bayer Description and Major Businesses
Table 61. Bayer Product Models, Descriptions and Specifications
Table 62. Bayer Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Bayer Sales Value Proportion by Product in 2024
Table 64. Bayer Sales Value Proportion by Application in 2024
Table 65. Bayer Sales Value Proportion by Geographic Area in 2024
Table 66. Bayer Dosage Control Syringe SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Merit Medical Corporation Information
Table 69. Merit Medical Description and Major Businesses
Table 70. Merit Medical Product Models, Descriptions and Specifications
Table 71. Merit Medical Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Merit Medical Sales Value Proportion by Product in 2024
Table 73. Merit Medical Sales Value Proportion by Application in 2024
Table 74. Merit Medical Sales Value Proportion by Geographic Area in 2024
Table 75. Merit Medical Dosage Control Syringe SWOT Analysis
Table 76. Merit Medical Recent Developments
Table 77. Medline Corporation Information
Table 78. Medline Description and Major Businesses
Table 79. Medline Product Models, Descriptions and Specifications
Table 80. Medline Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Medline Sales Value Proportion by Product in 2024
Table 82. Medline Sales Value Proportion by Application in 2024
Table 83. Medline Sales Value Proportion by Geographic Area in 2024
Table 84. Medline Dosage Control Syringe SWOT Analysis
Table 85. Medline Recent Developments
Table 86. MedNet Corporation Information
Table 87. MedNet Description and Major Businesses
Table 88. MedNet Product Models, Descriptions and Specifications
Table 89. MedNet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. MedNet Sales Value Proportion by Product in 2024
Table 91. MedNet Sales Value Proportion by Application in 2024
Table 92. MedNet Sales Value Proportion by Geographic Area in 2024
Table 93. MedNet Dosage Control Syringe SWOT Analysis
Table 94. MedNet Recent Developments
Table 95. Comed Corporation Information
Table 96. Comed Description and Major Businesses
Table 97. Comed Product Models, Descriptions and Specifications
Table 98. Comed Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Comed Recent Developments
Table 100. Argon Medical Devices Corporation Information
Table 101. Argon Medical Devices Description and Major Businesses
Table 102. Argon Medical Devices Product Models, Descriptions and Specifications
Table 103. Argon Medical Devices Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Argon Medical Devices Recent Developments
Table 105. Edges Medicare Corporation Information
Table 106. Edges Medicare Description and Major Businesses
Table 107. Edges Medicare Product Models, Descriptions and Specifications
Table 108. Edges Medicare Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Edges Medicare Recent Developments
Table 110. Advin Health Care Corporation Information
Table 111. Advin Health Care Description and Major Businesses
Table 112. Advin Health Care Product Models, Descriptions and Specifications
Table 113. Advin Health Care Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Advin Health Care Recent Developments
Table 115. SCW Medicath Corporation Information
Table 116. SCW Medicath Description and Major Businesses
Table 117. SCW Medicath Product Models, Descriptions and Specifications
Table 118. SCW Medicath Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. SCW Medicath Recent Developments
Table 120. Shanghai INT Medical Instruments Corporation Information
Table 121. Shanghai INT Medical Instruments Description and Major Businesses
Table 122. Shanghai INT Medical Instruments Product Models, Descriptions and Specifications
Table 123. Shanghai INT Medical Instruments Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Shanghai INT Medical Instruments Recent Developments
Table 125. Lepu Medical Technology Corporation Information
Table 126. Lepu Medical Technology Description and Major Businesses
Table 127. Lepu Medical Technology Product Models, Descriptions and Specifications
Table 128. Lepu Medical Technology Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Lepu Medical Technology Recent Developments
Table 130. Jiangxi Hongda Medical Equipment Group Corporation Information
Table 131. Jiangxi Hongda Medical Equipment Group Description and Major Businesses
Table 132. Jiangxi Hongda Medical Equipment Group Product Models, Descriptions and Specifications
Table 133. Jiangxi Hongda Medical Equipment Group Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Jiangxi Hongda Medical Equipment Group Recent Developments
Table 135. Shenzhen Antmed Corporation Information
Table 136. Shenzhen Antmed Description and Major Businesses
Table 137. Shenzhen Antmed Product Models, Descriptions and Specifications
Table 138. Shenzhen Antmed Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Shenzhen Antmed Recent Developments
Table 140. BrosMed Medical Corporation Information
Table 141. BrosMed Medical Description and Major Businesses
Table 142. BrosMed Medical Product Models, Descriptions and Specifications
Table 143. BrosMed Medical Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. BrosMed Medical Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Dosage Control Syringe Product Picture
Figure 2. Global Dosage Control Syringe Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 10ml Product Picture
Figure 4. 12ml Product Picture
Figure 5. 20ml Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dosage Control Syringe Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dosage Control Syringe Report Years Considered
Figure 12. Global Dosage Control Syringe Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 14. Global Dosage Control Syringe Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Dosage Control Syringe Revenue Market Share by Region (2020-2031)
Figure 16. Global Dosage Control Syringe Sales (2020-2031) & (M Units)
Figure 17. Global Dosage Control Syringe Sales (CAGR) by Region (2020-2031) (M Units)
Figure 18. Global Dosage Control Syringe Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Dosage Control Syringe Sales Volume Market Share in 2024
Figure 20. Global Dosage Control Syringe Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. 10ml Revenue Market Share by Manufacturer in 2024
Figure 23. 12ml Revenue Market Share by Manufacturer in 2024
Figure 24. 20ml Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Dosage Control Syringe Sales Market Share by Type (2020-2031)
Figure 27. Global Dosage Control Syringe Revenue Market Share by Type (2020-2031)
Figure 28. Global Dosage Control Syringe Sales Market Share by Application (2020-2031)
Figure 29. Global Dosage Control Syringe Revenue Market Share by Application (2020-2031)
Figure 30. North America Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
Figure 31. North America Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
Figure 33. North America Dosage Control Syringe Sales Volume (M Units) by Type (2020- 2031)
Figure 34. North America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
Figure 36. North America Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
Figure 41. Europe Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
Figure 43. Europe Dosage Control Syringe Sales Volume (M Units) by Type (2020-2031)
Figure 44. Europe Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
Figure 46. Europe Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 48. France Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
Figure 53. Asia-Pacific Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Dosage Control Syringe Sales Volume (M Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
Figure 58. Asia-Pacific Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 63. India Dosage Control Syringe Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
Figure 65. Central and South America Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Dosage Control Syringe Sales Volume (M Units) by Type (2021-2031)
Figure 68. Central and South America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
Figure 70. Central and South America Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Dosage Control Syringe Sales YoY (2020-2031) & (M Units)
Figure 74. Middle East and Africa Dosage Control Syringe Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Dosage Control Syringe Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Dosage Control Syringe Sales Volume (M Units) by Type (2021-2031)
Figure 77. South America Dosage Control Syringe Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Dosage Control Syringe Sales Volume (M Units) by Application (2020-2031)
Figure 79. Middle East and Africa Dosage Control Syringe Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Dosage Control Syringe Revenue (2020-2025) & (US$ Million)
Figure 84. Dosage Control Syringe Industry Chain Mapping
Figure 85. Regional Dosage Control Syringe Manufacturing Base Distribution (%)
Figure 86. Global Dosage Control Syringe Production Market Share by Region (2020-2031)
Figure 87. Dosage Control Syringe Production Process
Figure 88. Regional Dosage Control Syringe Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed